Core Viewpoint - The National Medical Products Administration (NMPA) is intensifying its "Clearing Source" campaign to regulate drug distribution and ensure public safety, highlighting a significant case involving illegal drug procurement by a pharmacy in Huizhou, Guangdong [1][2]. Group 1: Regulatory Actions - The NMPA has reported five typical cases of violations during the "Clearing Source" campaign, with a focus on the illegal procurement of drugs by Yanjiji Pharmacy in Huizhou [1][2]. - In January 2025, the Guangdong Provincial Drug Administration, along with local market supervision and police, conducted inspections that revealed the pharmacy's illegal activities, including purchasing drugs from unauthorized channels and failing to comply with storage regulations [2]. - The pharmacy was penalized with the confiscation of illegal drugs, a fine of 1.3 million yuan, closure of unauthorized storage facilities, and revocation of its drug business license [2]. Group 2: Local Government Response - The Huizhou Market Supervision Bureau recognized the case for its demonstrative effect and reported it to the NMPA as a typical example [3]. - The local authorities organized educational meetings for pharmacies to raise awareness and prevent similar violations, emphasizing a "zero tolerance" policy towards illegal drug procurement [3]. - The Huizhou government plans to strengthen drug quality supervision and maintain a robust regulatory network to ensure compliance with drug management laws [3]. Group 3: Compliance and Consumer Guidance - The NMPA stresses that drug businesses must purchase drugs from legal sources and maintain accurate records, adhering to quality management standards [4]. - Consumers are advised to buy drugs only from licensed pharmacies and to be cautious when purchasing online, ensuring that sellers have the necessary qualifications [4]. - It is recommended that consumers keep receipts and check drug packaging information, and report any quality issues or illegal sales to the relevant authorities [4].
罚款130万!惠州一药店被国家药监局通报
Nan Fang Du Shi Bao·2025-06-26 03:08